ArticleBrain & spine2026
No surgical site infections observed after lumbar unilateral biportal endoscopy: a multicenter retrospective series of 1566 patients.
Article in Brain & spine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Staphylococcus aureus surgical site infection following unilateral biportal endoscopic spine surgery: a two-case report.Frontiers in surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Surgical site infection (SSI) remains a concern in spinal surgery despite advances in minimally invasive techniques. Unilateral biportal endoscopy (UBE) may reduce infection risk via limited tissue trauma and continuous saline irrigation, but its true SSI incidence remains unknown. Research question: This study aimed to assess the incidence of SSI after lumbar UBE procedures. Material and methods: This retrospective multicenter study included consecutive patients who underwent lumbar UBE for degenerative conditions between March 2022 and January 2025 in four French spine centers. Secondary outcomes included other complications and functional recovery. Results: Among 1566 patients (mean age 58 ± 16 years; 53 % male), indications included disc herniation (59 %) and spinal stenosis (39 %). Half received perioperative antibiotic prophylaxis. No SSI occurred within 90 days after UBE. One SSI was observed after a subsequent open revision with fusion, unrelated to the initial procedure. Other complications occurred in 15 % of patients, including dural tears (5 %) and reoperations (4 %), mainly for recurrent herniation. At 3 months, ODI improved from 46 ± 19 to 20 ± 18, with a minimal clinically important difference achieved in 72 % of cases. Discussion and conclusion: No SSI was identified after lumbar UBE in this large multicenter series. Continuous irrigation and minimal tissue trauma may confer a protective effect, supporting UBE as a safe minimally invasive approach with extremely low infection risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.